Dentsply International | XRAY - Sales Revenues

Stock Price
11.75
Daily Change
0.27 2.35%
Monthly
1.29%
Yearly
-15.65%
Q2 Forecast
11.66

Dentsply International reported $961M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
3M USD 6B 100M Mar/2026
Agilent USD 1.8B 63M Dec/2025
Align Technology USD 1.04B 10M Mar/2026
Bruker USD 977.2M 116.7M Dec/2025
Cardinal Health USD 60.9B 4.73B Mar/2026
Charles River Laboratories USD 994.2M 5.8M Dec/2025
Cooper Companies USD 1.02B 41.1M Dec/2025
CVS Health USD 105.7B 2.8B Dec/2025
Danaher USD 5.95B 890M Mar/2026
Dentsply International USD 961M 57M Dec/2025
Henry Schein USD 3.4B 60M Dec/2025
Idexx Laboratories USD 1.09B 10M Dec/2025
Illumina USD 1.09B 70M Mar/2026
Integra LifeSciences USD 434.9M 32.84M Dec/2025
Intuitive Surgical USD 2.77B 100M Mar/2026
IQVIA Holdings USD 4.36B 260M Dec/2025
McKesson USD 106.16B 3.01B Dec/2025
Medtronic USD 9B 39M Jan/2026
Mettler Toledo International USD 1.13B 100M Dec/2025
Owens Minor USD 708.97M 11.71M Dec/2025
Repligen USD 197.91M 8.91M Dec/2025
Revvity USD 772.06M 73.06M Dec/2025
Smith & Nephew USD 3.18B 353M Dec/2025
Stryker USD 6B 1.2B Mar/2026
Thermo Fisher Scientific USD 11.01B 1.2B Mar/2026
Veradigm USD 142.52M 9.38M Dec/2022
Waters USD 932M 132M Dec/2025
Zimmer Biomet Holdings USD 2.09B 150M Mar/2026
Zoetis USD 2.4B 0 Dec/2025